Home » Johnson & Johnson Completes Acquisition of TransForm
Johnson & Johnson Completes Acquisition of TransForm
April 5, 2005
Johnson & Johnson announced that it has completed its acquisition of TransForm Pharmaceuticals, Inc., a Lexington, Mass.-based company specializing in the discovery of superior formulations and novel crystalline forms of drug molecules. The transaction was completed as announced on March 9, 2005. Johnson & Johnson, through its operating companies, is the world's most comprehensive and broadly based manufacturer of healthcare products, as well as a provider of related services, for the consumer, pharmaceutical, and medical devices and diagnostics markets.
BioSpace (http://www.biospace.com/news_story.cfm?StoryID=19591520&full=1)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct